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Abstract - The development of nasopharyngeal carcinoma (NPC) is the result of interaction between Epstein-Barr Virus 
(EBV) and many non-viral factors. The aims of this study were to determine the prevalence of EBV in NPC biopsies from 
Serbian patients and to investigate the correlation between EBV presence and demographic, anamnestic and clinical data. 
Ninety-three tissue blocks were included. For detection of EBV DNA, the C terminus of the LMP1 gene was amplified 
by nested-PCR. Twenty-eight biopsies were EBV-DNA-positive (30.1%), with a statistically significant difference in EBV 
DNA presence between geographical regions (p=0.02) and between the stages of tumor-node-metastasis (TNM) (p=0.02). 
A correlation was also found with the presence of EBV DNA and smoking (p=0.02). The correlation of EBV DNA pres-
ence, with or without smoking and the promising outcome of the disease was statistically significant (p=0.02; p=0.01). The 
EBV DNA findings from this study confirm the role of EBV in NPC carcinogenesis, and show the different distribution 
among TNM stages and correlation between the virus and outcome of disease.
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INTRODUCTION
Nasopharyngeal carcinoma (NPC) is a human ma-
lignancy that is rare in most populations around the 
world. However, in South China and Southeast Asia, 
NPC is endemic, with incidence rates of 20-30 per 
100 000 person-years (Jia and Qin, 2012). In Serbia, 
the  undifferentiated  carcinoma  of  nasopharyngeal 
type (UCNT, WHO type III) is dominant, as is case 
in high-risk areas, but with similar incidence to that 
found in Europe and the USA, 0.5-1 per 100 000 per-
son-years (Jemal et al., 2011). 
The development of NPC is the result of a complex 
interaction between early Epstein-Barr virus (EBV) 
infection, genetic factors and environmental carcin-
ogens, which is shown in the clustering in families of 
diverse populations (Zeng, 2002). UCNT is univer-
sally associated with EBV, a human gammaherpes-
virus that establishes a life-long, persistent infection 
in more than 90% of the population worldwide. This 
virus was classified as a group 1 carcinogenic agent 
by the IARC (International Agency for Research and 
Cancer). The discovery of EBV receptors on pharyn-
geal epithelial cells, as well as monoclonal viral epi-
somes in UCNT tissues, has established the relation 
between EBV and NPC (Siegler et al., 2004; Raab-
Traub and Flynn, 1986). The switch from the latent to 
the lytic phase of the infection is probably one of the 
crucial steps in NPC development. This switch could 
be identified by several specific serologic biomark-
ers widely used for the screening and early diagnosis 538 ANA BANKO ET AL.
of UCNT in high-risk populations in South China. 
These  biomarkers  include  antibodies  against  EBV 
lytic gene products, anti-VCA IgA and anti-Zta IgA 
(Chien et al., 2001). However, these markers can lack 
specificity,  and  usually  remain  elevated  even  after 
disease remission is achieved. Moreover, increasing 
plasma EBV DNA could be detected as a marker for 
the reactivation of viral replication, but in contrast to 
serology, it is also used for monitoring patients and 
predicting the outcome of treatment as it correlates 
well with tumor burden (Wang et al., 2010). The es-
sential viral oncoprotein is latent membrane protein 
1 (LMP1), an integral membrane protein that pro-
motes the immortalization of B lymphocytes by in-
ducing B-cell activation markers and expression of 
the antiapoptotic A20 and bcl-2 genes (Rowe et al., 
1994; Kulwichit et al., 1998). 
No specific natural inducer of EBV reactivation 
in NPC has been identified. However, epidemiologi-
cal studies have determined several lifestyle risk fac-
tors for NPC, especially tobacco smoking, consump-
tion of salt-preserved fish, consumption of preserved 
vegetables or inadequate intakes of fresh vegetables 
and fruits, and occupational exposure to chemicals 
(Chang and Adami, 2006). Although several chemi-
cals (phorbol-12-myristate-13-acetate-TPA, sodium 
butyrate and trichostatin A) have been described as 
inducers of the EBV lytic cycle, smoking has been 
shown as the only lifestyle risk factor for NPC linked 
to EBV seropositivity (Xu et al., 2012). Moreover, 
chromosomal 3p loss of heterozygosity (LOH), spe-
cific human leukocyte antigen HLA polymorphisms 
and some other loci outside the (HLA) region also 
show  association  with  NPC  risk.  They  represent 
“pre-malignancy” genetic status of the epithelial cells 
where carcinogenesis develops (Jia and Quin, 2012).
The aims of the present study were: (i) to deter-
mine the prevalence of EBV in biopsy specimens of 
nasopharyngeal  carcinoma  from  Serbian  patients, 
and (ii) to investigate the correlation between EBV 
presence  and  demographic  and  anamnestic  data, 
TNM (tumor-node-metastasis) staging and therapy 
effect in UCNT patients.
MATERIALS AND METHODS
Patients and samples
This study included 93 patients with histologically 
confirmed undifferentiated carcinoma of nasopha-
ryngeal type (UCNT) after endoscopic biopsy. After 
diagnosis, they were treated with radiotherapy (RT) 
as  the  mainstay  treatment;  some  were  also  treat-
ed  with  chemotherapy  (CT),  chemo-radiotherapy 
(CRT), surgically or only symptomatically.
Archived tissue blocks from the 93 patients, fixed 
in formalin and embedded in paraffin, were retrieved 
from the Clinic of Otorhinolaryngology and Maxil-
lofacial Surgery, Clinical Center of Serbia. Accord-
ing to accessible data, all patients were classified by 5 
different criteria: sex (male, female); region of living 
(Vojvodina, Beograd, Šumadija and western Serbia, 
south  and  east  Serbia,  Kosovo  and  Metohija);  to-
bacco smoking (smokers, non-smokers), TNM stag-
ing by the American Joint on Cancer (AJCC) (Tx, I, 
II, III, IV); and the last known outcome of disease 
(Th-therapy  in  progress,  CR-complete  remission, 
PR-partial regression, S-stabilization, P-progression 
and/or metastasis). Age ranged from 18 to 76 years 
(mean 52.9±1.4 years).
Deparaffinization and DNA Isolation
Three 10-mm-thick tissue sections from each block 
were placed in a sterile, plastic 1.5-ml PCR tube, de-
paraffinized with xylene, rehydrated in alcohol, and 
then air-dried. The tissue was then resuspended and 
lysed overnight in 180 µl digestion buffer (QIAGEN, 
Hilden, Germany) and 20 µl proteinase K (QIAGEN, 
Hilden, Germany) at 560C. Viral DNA was isolated 
using a QIamp Mini Kit (QIAGEN, Hilden, Germa-
ny) according to the manufacturer’s instructions.
PCR for Detection of LMP1
Amplification of the C terminus of the LMP1 gene 
was performed by nested PCR using primers flank-
ing the characteristic 30-bp deletion region: OF 8081: 
5’- GCTAAGGCATTCCCAGTAAA-3’ and OR 8744: EBV IN NPC FROM SERBIAN PATIENTS 539
5’-GATGAACACCACCACGATG-3’ as outer prim-
ers, and IF 8213: 5’-CGGAACCAGAAGAACCCA-3’ 
and IR 8719: 5’-TCCCGCACCCTCAACAAG-3’ as 
inner primers, as previously described by Li et al. 
(2009). The PCR reactions were carried out in 40 
cycles at 950C for 1 min, at 470C for 1 min, and at 
720C for 1 min. PCR products were analyzed using 
gel electrophoresis with ethidium-bromide staining.
Statistical analyses
For statistical analyses, the chi-squared and Spear-
man rank correlation tests were used. Analysis was 
performed  by  SPSS  v.15  for  Windows  (SPSS  Inc., 
Chicago, IL) software. P<0.05 was considered sig-
nificant.
RESULTS
Twenty-eight of the ninety-three tested tissue sam-
ples were positive for EBV DNA (30.1%). Patients’ 
data from 5 different categories were obtained, and 
the results are summarized in Table 1.
To investigate a potential correlation between car-
cinoma tissue finding of EBV DNA and patient data 
Fig. 1. Regional distribution of EBV positive and EBV negative biopsies from NPC patients540 ANA BANKO ET AL.
Fig. 2. Distribution of EBV positive and negative biopsies with and without association with smoking according to TNM stage
EBV – number of positive and negative patients according to EBV DNA presence
EBV/smoking –– number of positive and negative patients according to association of EBV DNA presence and tobacco smoking
Fig. 3. Distribution of EBV positive and negative biopsies with and without association with smoking according to last known outcome 
of disease
EBV – number of positive and negative patients according to EBV DNA presence
EBV/smoking –– number of positive and negative patients according to association of EBV DNA presence and tobacco smokingEBV IN NPC FROM SERBIAN PATIENTS 541
from 5 categories, statistical analysis was performed. 
A significant difference in the EBV DNA presence 
between regions of living (χ2=12.07, p=0.02) (Fig. 1) 
was observed. It has also been shown that there was 
a significant difference in EBV DNA-positive biop-
sies and TNM staging (χ2=11.39, p=0.02), even if the 
positive finding of EBV DNA was associated with to-
bacco smoking (χ2=12.13, p=0.02) (Fig. 2). The high-
est frequencies were found at early TNM stages, es-
pecially TNM I.
The  correlation  of  EBV  DNA  presence  and  a 
promising outcome of the disease (patients receiving 
therapy and patients with complete remission) was 
shown to be statistically significant (ρ=0.29, p=0.02). 
However, the correlation between a promising out-
come of disease was highly significant when EBV 
DNA presence was associated with tobacco smoking 
(ρ=0.32, p=0.01) (Fig. 3).
The differences in the EBV DNA presence be-
tween sex, age or tobacco smoking habit did not reach 
statistical significance (p>0.05). Statistical analysis of 
the difference between demographic, anamnestic and 
clinical data revealed a significant difference only be-
tween sex and TNM staging (χ2=14.62, p=0.01).
DISCUSSION
UCNT is type of NPC that is, in almost all cases, 
EBV-positive,  irrespective  of  geographical  origin 
(Ozyar et al., 2004). It has been suggested that ac-
tivated EBV might have a different impact on NPC 
tumorigenesis during different stages. At the early 
stage, the reactivation of EBV in B cells might fa-
cilitate nasopharyngeal epithelial cell infection with 
EBV by cell-to-cell contact. Changing cytokine were 
observed to effectively enhance EBV infection in the 
nasopharyngeal epithelial cells (Tsang et al., 2010). 
Table 1. Distribution of patients according to five different criteria
Category
Number and valid percent of patients
Missing data
Sex
Male
67 (72%)
Female
26 (28%)
0
Region of living
Vojvodina
3 (3.3%)
Belgrade
43 (47.3%)
Šumadija and west 
Serbia
24 (26.4%)
South and east 
Serbia
17 (18.7%)
Kosovo and Me-
tohija
4 (4.4%)
2
Tobacco smoking
Smokers
43 (64.2%)
Non-smokers
24 (35.8%)
26
TNM staging a Tx
12 (12.9%)
I
4 (4.3%)
II
26 (28%)
III
20 (21.5%)
IV
31 (33.3%)
0
The last known  
outcome of disease b
Th
5 (7.8%)
CR
20 (31.3%)
PR
6 (9.4%)
S
5 (7.8%)
P
28 (43.8%)
29
a TNM staging by The American Joint on Cancer (AJCC): tumor-node-metastasis 
b Therapy in progress (Th), Complete remission (CR), Partial regression (PR), Stabilization (S), Progression and/or metastasis (P)542 ANA BANKO ET AL.
Although EBV DNA was detected in only 30.1% of 
samples, this is in accordance with the hypothesis 
concerning the early oncogenic involvement of EBV 
(Perez-Ordonez, 2007). In support of this hypothesis 
is the observation that more than 75% of biopsies 
from the early TNM stage were EBV-positive. This 
was found for archived biopsies that were not proc-
essed immediately after incision, which is known to 
potentially decrease the probability of viral DNA iso-
lation. 
Although  human  genetic  variation  has  an  in-
fluence on the development of NPC, differences in 
lifestyle and dietary factors, in concert with environ-
mental factors, are likely to increase the risk of de-
veloping this cancer and lead to the unique distribu-
tion of NPC. The regional diversity of EBV-positive 
UCNT patients in Serbia could be caused by different 
combinations of all these factors added to individual 
genetic  predisposition,  especially  smoking  habits, 
EBV infection and occupational exposures to chemi-
cals. Therefore, in view of the absence of data about 
the patients’ occupations, it might be assumed that 
the lowest frequency of EBV-positive biopsies from 
patients living in south and east Serbia are the result 
of the domination of chemicals and toxins from the 
many industrial zones in this region. The association 
of NPC and formaldehyde, wood dust, solvents such 
as  phenoxy  acid  and  chlorophenol  were  reported 
previously (Thompson and Grafström, 2009; Hild-
esheim et al., 2001; Hardell et al., 1982). Together 
with EBV reactivation, these carcinogens may lead 
to a dramatic change in genome stability (Fang et al., 
2012).
According to the results from this study, the pres-
ence of EBV DNA is correlated with a promising out-
come of disease. Interestingly, it was found that EBV 
DNA presence associated with tobacco smoking also 
correlates with a promising outcome of disease. This 
is an important contribution to the hypothesis that 
the presence of the EBV genome and EBV antigens 
might become a specific factor of vulnerability for 
the malignant cells and immunotherapeutic target 
for novel therapeutic approaches (Lin et al., 2002). 
Tobacco  smoking  produces  several  reactive 
forms of agents resulting in the formation of DNA 
adducts  which  cause  DNA  damage.  However,  in 
NPC patients, especially UCNT, smoking may play 
an alternative role via induction of EBV reactivation, 
as demonstrated earlier (Xu et al., 2012). Among Ser-
bian patients, smokers’ frequency was approximately 
65%, which correlates with previously reported data 
(Anghel et al., 2012). Moreover, smoking contribut-
ed to EBV presence in biopsy cells and was more fre-
quent in a promising outcome of disease, but also in 
the early TNM stages. Thus, the association of EBV 
presence and tobacco smoking in clinical entities of 
Serbian patients correlates with the “smoking driven 
model” of inducing EBV reactivation (Jia and Quin, 
2012; Xu et al., 2012). 
Consistent with the reported data was the fre-
quency of UCNT found in males (2.6-fold higher 
than in females) (Brennan, 2006, Anghel et al., 2012). 
The difference between sexes may reflect the effects 
of habit and lifestyle diversity or potential biological 
particularities. The peak of age for acquiring this tu-
mor was between 50 and 59, which is in accordance 
with data from high-risk areas where UCNT is the 
dominant type of NPC, as observed in neighboring 
Romania (Chang and Adami, 2006; Anghel et al., 
2012).
Although the etiological mechanism of the la-
tent-to-lytic phase transformation of EBV is unclear, 
the EBV DNA findings from this study confirm the 
role of EBV in NPC carcinogenesis. Also shown are 
the association of EBV positivity with tobacco smok-
ing,  the  different  distribution  among  TNM  stages 
and the correlation between the virus and outcome 
of disease. 
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